Replies to post #422049 on NorthWest Biotherapeutics Inc (NWBO)

[MalteseFalcon]

99.99999% It's the way forward and the Phase 1 trial for Direct paves the way. The new trials will likely be single armed and measured against existing standard of care. This will shorten length of trial to probably only 1 year before read-out.